Harry Yang
Impact in
- Statistics and Probability top 5%
- Statistical Methods in Clinical Trials
-
- Biosimilars and Bioanalytical Methods
Papers in ⓘ
-
- Statistical Methods in Clinical Trials 26
-
- Protein purification and stability 9
- Co-authors
- Lanju Zhang (10 shared papers)Kris F. Sachsenmeier (2 shared papers)Robert E. Hollingsworth (1 shared paper)Erin Sult (1 shared paper)Jeffrey M. Leiden (1 shared paper)Craig B. Thompson (1 shared paper)X. Mao (1 shared paper)Susan Miesfeldt (1 shared paper)
- Journals
- Statistics in Biopharmaceutical Research (9 papers)Journal of Biopharmaceutical Statistics (9 papers)PDA Journal of Pharmaceutical Science and Technology (7 papers)Journal of Immunological Methods (4 papers)Journal of Pharmaceutical and Biomedical Analysis (3 papers)
- Partner nations
- United StatesSlovakiaSlovenia
In The Last Decade
Harry Yang
54 papers receiving 889 citations
Peers
Comparison fields: 5 of 131
- Statistics and Probability 85
- Immunology 183
- Molecular Biology 493
- Radiology, Nuclear Medicine and Imaging 142
- Pharmaceutical Science 36
Countries citing papers authored by Harry Yang
This map shows the geographic impact of Harry Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry Yang more than expected).
Fields of papers citing papers by Harry Yang
This network shows the impact of papers produced by Harry Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry Yang. The network helps show where Harry Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Harry Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 265 | |
| 2 | 2014 | 192 | |
| 3 | 1994 | 111 | |
| 4 | 2013 | 40 | |
| 5 | 2013 | 28 | |
| 6 | 2000 | 18 | |
| 7 | 2010 | 17 | |
| 8 | 2012 | 16 | |
| 9 | 2013 | 14 | |
| 10 | 2009 | 14 | |
| 11 | 2018 | 12 | |
| 12 | 2012 | 12 | |
| 13 | 2017 | 11 | |
| 14 | 2020 | 10 | |
| 15 | 2014 | 10 | |
| 16 | 2012 | 10 | |
| 17 | 2014 | 9 | |
| 18 | 2009 | 9 | |
| 19 | 2011 | 9 | |
| 20 | 2019 | 8 |
About Harry Yang
Harry Yang is a scholar working on Statistics and Probability, Molecular Biology, Immunology, Management Science and Operations Research and Statistics, Probability and Uncertainty, having authored 57 papers that have together received 920 indexed citations. Recurring topics across this work include Statistical Methods in Clinical Trials (26 papers), Biosimilars and Bioanalytical Methods (16 papers), Protein purification and stability (9 papers), Optimal Experimental Design Methods (7 papers), Advanced Statistical Process Monitoring (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Pesticide Residue Analysis and Safety (5 papers) and SARS-CoV-2 detection and testing (4 papers). The work is most often cited by research in Statistics and Probability (85 citations), Immunology (183 citations), Molecular Biology (493 citations), Radiology, Nuclear Medicine and Imaging (142 citations) and Pharmaceutical Science (36 citations). Harry Yang has collaborated with scholars based in United States, Slovakia and Slovenia. Frequent co-authors include Lanju Zhang, Kris F. Sachsenmeier, Robert E. Hollingsworth, Erin Sult, Jeffrey M. Leiden, Craig B. Thompson, X. Mao, Susan Miesfeldt, Steven Novick and Robert Kubiak. Their work appears in journals such as Statistics in Biopharmaceutical Research, Journal of Biopharmaceutical Statistics, PDA Journal of Pharmaceutical Science and Technology, Journal of Immunological Methods and Journal of Pharmaceutical and Biomedical Analysis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.